Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 1.27
NAS:ATNX's Cash-to-Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: 1.27 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:ATNX' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.27  Med: 8.27 Max: 15.28
Current: 1.27
1.27
15.28
Equity-to-Asset 0.32
NAS:ATNX's Equity-to-Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: 0.32 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:ATNX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.56 Max: 0.81
Current: 0.32
0.32
0.81
Interest Coverage N/A
NAS:ATNX's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: N/A )
Ranked among companies with meaningful Interest Coverage only.
NAS:ATNX' s Interest Coverage Range Over the Past 10 Years
Min: N/A  Med: N/A Max: N/A
Current: N/A
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -417.24
NAS:ATNX's Operating Margin % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: -417.24 )
Ranked among companies with meaningful Operating Margin % only.
NAS:ATNX' s Operating Margin % Range Over the Past 10 Years
Min: -417.24  Med: -390.45 Max: -363.65
Current: -417.24
-417.24
-363.65
Net Margin % -426.82
NAS:ATNX's Net Margin % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: -426.82 )
Ranked among companies with meaningful Net Margin % only.
NAS:ATNX' s Net Margin % Range Over the Past 10 Years
Min: -426.82  Med: -394.85 Max: -362.88
Current: -426.82
-426.82
-362.88
ROE % -146.10
NAS:ATNX's ROE % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: -146.10 )
Ranked among companies with meaningful ROE % only.
NAS:ATNX' s ROE % Range Over the Past 10 Years
Min: -146.1  Med: -98.99 Max: -51.87
Current: -146.1
-146.1
-51.87
ROA % -77.51
NAS:ATNX's ROA % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: -77.51 )
Ranked among companies with meaningful ROA % only.
NAS:ATNX' s ROA % Range Over the Past 10 Years
Min: -77.51  Med: -59.77 Max: -42.02
Current: -77.51
-77.51
-42.02
ROC (Joel Greenblatt) % -1417.42
NAS:ATNX's ROC (Joel Greenblatt) % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. NAS:ATNX: -1417.42 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:ATNX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1417.42  Med: -1111.86 Max: -806.3
Current: -1417.42
-1417.42
-806.3
GuruFocus has detected 1 Warning Sign with Athenex Inc $NAS:ATNX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:ATNX's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with NAS:ATNX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: »  
Compare:NAS:ADOM, NAS:CGBD, NYSE:GPMT, NYSE:APRN, NYSE:WOW, NAS:DOVA, NYSE:BY, NAS:GTHX, NAS:AKCA, NYSE:CARS, NYSE:SAFE, NAS:SGH, NYSE:SMHI, NAS:MRSN, NAS:PIXY, NAS:NESR, NAS:MMDM, NYSE:ETX, NAS:TNTR, NAS:ALRN » details
Traded in other countries:2MT.Germany,
Headquarter Location:USA
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company's mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. The company has organized its business model into three segments, Oncology Innovation Platform, Commercial Platform and Global Supply Chain Platform with operations in both the U.S. and China.

Ratios

vs
industry
vs
history
PB Ratio 23.05
ATNX's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 23.05 )
Ranked among companies with meaningful PB Ratio only.
ATNX' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.76
Current: 23.05
0
24.76
EV-to-EBIT -11.96
ATNX's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: -11.96 )
Ranked among companies with meaningful EV-to-EBIT only.
ATNX' s EV-to-EBIT Range Over the Past 10 Years
Min: -12.85  Med: 0 Max: 0
Current: -11.96
-12.85
0
EV-to-EBITDA -12.25
ATNX's EV-to-EBITDA is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: -12.25 )
Ranked among companies with meaningful EV-to-EBITDA only.
ATNX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.16  Med: 0 Max: 0
Current: -12.25
-13.16
0
Current Ratio 1.85
ATNX's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 1.85 )
Ranked among companies with meaningful Current Ratio only.
ATNX' s Current Ratio Range Over the Past 10 Years
Min: 1.85  Med: 2.78 Max: 3.7
Current: 1.85
1.85
3.7
Quick Ratio 1.70
ATNX's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 1.70 )
Ranked among companies with meaningful Quick Ratio only.
ATNX' s Quick Ratio Range Over the Past 10 Years
Min: 1.7  Med: 2.61 Max: 3.52
Current: 1.7
1.7
3.52
Days Inventory 69.38
ATNX's Days Inventory is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 69.38 )
Ranked among companies with meaningful Days Inventory only.
ATNX' s Days Inventory Range Over the Past 10 Years
Min: 69.38  Med: 79.87 Max: 90.36
Current: 69.38
69.38
90.36
Days Sales Outstanding 49.32
ATNX's Days Sales Outstanding is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 49.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
ATNX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.32  Med: 74.82 Max: 100.31
Current: 49.32
49.32
100.31
Days Payable 132.80
ATNX's Days Payable is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: 132.80 )
Ranked among companies with meaningful Days Payable only.
ATNX' s Days Payable Range Over the Past 10 Years
Min: 132.8  Med: 153.41 Max: 174.02
Current: 132.8
132.8
174.02

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) % -8.36
ATNX's Earnings Yield (Greenblatt) % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. ATNX: -8.36 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ATNX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -12.43  Med: 0 Max: 0
Current: -8.36
-12.43
0

More Statistics

Revenue (TTM) (Mil) $20.55
EPS (TTM) $ -2.27
Short Percentage of Float0.11%
52-Week Range $11.21 - 20.79
Shares Outstanding (Mil)56.04

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 22 25 28
EPS ($) -1.63 -1.57 -1.50
EPS without NRI ($) -1.63 -1.57 -1.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for NAS:ATNX

Headlines

Articles On GuruFocus.com
Athenex, Inc. Announces Commencement of Patient Enrollment for Oraxol-plus-Ramucirumab Phase 1b Clin Jul 19 2017 
Athenex Pharmaceutical Division Receives FDA Clearance to Import Sodium Bicarbonate 8.4% Injection t Jul 12 2017 
Athenex, Inc. Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Optio Jun 19 2017 
Nasdaq Welcomes Athenex, Inc. (Nasdaq: ATNX) to The Nasdaq Stock Market Jun 14 2017 
Athenex, Inc. Announces Pricing of Initial Public Offering Jun 14 2017 
Athenex, Inc. (Nasdaq: ATNX) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO Jun 14 2017 

More From Other Websites
[$$] Clinical Development News, July 17-21 Jul 21 2017
IPO Market Back On Track: ETFs to Tap Jul 12 2017
Athenex Pharmaceutical Division Receives FDA Clearance to Import Sodium Bicarbonate 8.4% Injection... Jul 12 2017
Athenex Wins Big on Chinese Cancer Drug Jul 05 2017
Athenex, Inc. Announces Submission of Investigational New Drug Application of Oraxol to Chinese FDA Jul 05 2017
IPO Market Reignites With Strong Quarterly Performance Jun 30 2017
Athenex, Inc. Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment... Jun 19 2017
IPOs This Week: Cable Company Altice Leads a Busy Week Jun 18 2017
[$$] Biotech's Athenex Climbs in Trading Debut Jun 14 2017
Athenex's stock soars in its public debut Jun 14 2017
Nasdaq Welcomes Athenex, Inc. (Nasdaq: ATNX) to The Nasdaq Stock Market Jun 14 2017
Athenex's stock to debut on the Nasdaq after pricing IPO to raise $66 million Jun 14 2017
Athenex, Inc. Announces Pricing of Initial Public Offering Jun 14 2017
Athenex, Inc. (Nasdaq: ATNX) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO Jun 14 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}